The 2017 report comes at a time when the international community has acted decisively to achieve consensus on a way forward for joint action.
WHO Western Pacific Regional Office invited ANPUD in the capacity of temporary advisor to its biennial National HIV, Hepatitis and STI Programme Managers Meeting for Selected Asian and Pacific Countries from 27-30 June 2017 in Manila, Philippines. Mr. Rajiv Kafle, ANPUD’s regional secretariat, delivered the statement on behalf of ANPUD in the meeting.
The Coalition of Drug Users in Nepal (CDUN) is an alliance of all the drug user network organizations. We aim to promote best practices and evidence generated through project processes, to inform Health, Human Rights and Social Policy, in order to create a larger social impact for Drug Users.
Over 300 people from church, politic, culture, drugs Help- and human rights structures from Germany, Switzerland, Austria, Netherlands, Belgium, France, UK, Italy, Spain, Czech Republic, Norway, Slovenia, Canada, Australia, South Africa , El Salvador, Argentina, Mexico, Hong Kong and the USA have appealed to the Pope in Rome.
The whole point of criminalizing drug use is to stigmatize drug users. Consider why particular acts are seen as crimes in the first place.
ANPUD recognizes that the situation of women who use drugs (WUD) in the region is dire and needs urgent attention. To ensure such voices are represented within ANPUD and at the regional and international fora, the call for self-nomination for the women representative to the ANPUD Executive Board has been made. The deadline to submit the application is May 15, 2017 and women members are encouraged to contact the ANPUD secretariat before May 8, 2017 to clarify any queries they may have regarding the application process.
The purpose of this Technical Brief is to assist Global Fund applicants in their efforts to include and expand programs to remove human rights and gender-related barriers to HIV prevention, diagnosis and treatment services. This Brief discusses the barriers these programs help to remove, the various forms the programs take, the need to cost and allocate budget for them, and how to implement them in effective ways and at appropriate scale. It also aims to help stakeholders ensure that, as they are rolled out, HIV health services and programs promote and protect human rights and gender equality.
The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality. It presents data along the five strategic directions (strategic information, interventions, equity, financing and innovation) – key pillars of the GHSS to facilitate monitoring of progress in countries, regions and globally, and to measure the impact of interventions on reducing new infections and
saving lives between 2015 and 2030.
The tool describes how services can be designed and implemented to be accessible and acceptable to people who inject drugs. This requires respectful and ongoing engagement, and this publication gives particular attention to programmes run in close partnership with, or by, organizations of people who use drugs.
HCV prevalence in Asia and the Pacific varies between countries. HCV infection is due to unsterile medical injections (2 , 3) contaminated blood transfusions, (4) traditional cultural practices60 and, more recently, injecting drug use. (5) While iatrogenic transmission still occurs in some countries, transmission as the result of injecting drug use is increasing. (6)